Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. EFFECT Other Notice of Effectiveness
  7. ARS Other Annual Report to Security Holders
  8. DEFA14A Proxy Proxy Materials
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. DEFA14A Proxy Proxy Materials
  17. ARS Other Annual Report to Security Holders
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. EFFECT Other Notice of Effectiveness
  20. DEFA14A Proxy Proxy Materials

Page 4 of 5 · 93 filings